Mark Foley is President & CEO of Revance Therapeutics. Based in Nashville, Tennessee.
Mark Foley is President & CEO of Revance Therapeutics. He is also an active investor and board member for several healthcare companies, including uLab, HintMD, Arrinex (acquired by Stryker), and Glaukos Corporation. Previously, he was Chairman, President & CEO of ZELTIQ Aesthetics until its acquisition by Allergan for approximately $2.5 billion in 2017. With over 30 years of medical device operating, investment, and CEO experience, he has held roles at companies like U.S. Surgical Corporation, Guidant Corporation, and was the founder and CEO of Ventrica.
Full founder directory · Investor directory · Company funding database · Fundraising library